Pharmaceutical giants like J&J, Merck, and Eli Lilly are prioritizing AI training to enhance productivity in drug development. They aim to upskill thousands of employees in generative AI, which is expected to streamline processes and improve efficiency. This initiative reflects a broader trend in the industry to integrate advanced technologies into core operations.
Johnson & Johnson has already trained over 56,000 employees in generative AI, enabling them to utilize AI tools effectively. Merck's proprietary platform, GPTeal, allows employees to access large language models while ensuring data security. Eli Lilly encourages its workforce to embrace AI tools like ChatGPT, fostering a culture of innovation and technological literacy.
• J&J trained over 56,000 employees in generative AI for productivity.
• Merck's GPTeal platform enhances employee access to AI tools securely.
Generative AI is used to create content and streamline processes in drug development.
AI training is essential for employees to effectively utilize AI technologies in their roles.
Large language models enable employees to generate text and automate documentation tasks.
Johnson & Johnson integrates AI training to enhance employee skills and productivity in drug development.
Merck's GPTeal platform provides secure access to AI tools, improving operational efficiency.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.